This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Researchers analyzed 33,744 fee-for-service Medicare decedents with distant-stage breast, prostate, pancreatic, or lung cancers who died between 2014 and 2019.
Medscape Medical News